On June 1, 2015, Mylan (NASDAQ: MYL) sent a letter to Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) Chief Executive Officer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE